Antimicrobial Awareness Week 2021: Surgical site infections worsening globally
More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die because of complications caused by resistance to antibiotics, according to 2019 data by the Centers for Disease Control (CDC).
Antimicrobial Resistance (AMR) occurs when infecting microorganisms become non-responsive to antimicrobials, as the microbes develop some intrinsic inheritable changes over time.
Infection, therefore, becomes difficult to treat. This leads to risk of disease spread, severe illness and in some cases, death.
Irrational use of antibiotics is one of the important factors contributing to genesis of multidrug resistant bacteria or microorganisms.
An alarming global spread of ‘superbugs’ such as Carbapenem-resistant Enterobacteriaceae (CRE), Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), multidrug-resistant Pseudomonas aeruginosa, etc has become a cause of concern.
Patients who develop infections caused by resistant micro-pathogens are at an increased risk of mortality, morbidity and longer hospital stays.
AMR in surgical settings
The development of antibiotic resistance mechanisms by these bacterial strains has put forward multiple challenges to manage surgical site infections (SSI) globally.
SSIs are the third-most common hospital-acquired infections, accounting for 38 per cent of all nosocomial infections, according to the National Nosocomial Infection Surveillance System of the CDC.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.